Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP003488priorityCriticalpatent/ECSP003488A/en
Publication of ECSP003488ApublicationCriticalpatent/ECSP003488A/en
La invención se refiere a compuestos de fórmula (gráfico), y a sales promedicamentos y solvatos de estos farmacéuticamente aceptables, en los que R1, R", R3, R4, R5, R17, Rf A, X, e Y son como se definieron anteriormente. La invención también se refiere a composiciones farmacéuticas que contienen los compuestos de fórmulas I en el tratamiento de infecciones ya procedimientos de preparación de los compuestos de fórmula I.The invention relates to compounds of formula (graphic), and pharmaceutically acceptable salts and solvates thereof, in which R1, R ", R3, R4, R5, R17, Rf A, X, and Y are as defined above. The invention also relates to pharmaceutical compositions containing the compounds of formulas I in the treatment of infections and to methods of preparing the compounds of formula I.
ECSP0034882000-05-232000-05-23
DERIVATIVES OF 13- METHYLERYTHROMYCIN
ECSP003488A
(en)
NON-PEPTIDIC INHIBITING COMPOUNDS OF THE VLA-4 DEPENDENT CELL UNION IN THE TREATMENT OF INFLAMMATORY, AUTOIMMUNE AND RESPIRATORY DISEASES; PHARMACEUTICAL COMPOSITION AND TREATMENT PROCEDURE
COMPOUNDS DERIVED FROM 3H-QUINAZOLIN-4-ONA, ITS PREPARATION PROCESS, PHARMACEUTICAL COMPOSITION CONTAINING THEM, AND USE IN THE TREATMENT AND PREVENTION OF DISEASES MEDIATED BY MAO-B INHIBITORS, SUCH AS THE DISEASE OF ALZHEIMER AND DEMENCIER
ANTI-TUMOR AND ANTIVIRAL RENTAL AGENTS, PROCEDURE FOR THEIR PREPARATION, USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT AND PHARMACEUTICAL COMPOSITION CONTAINING SUCH AGENTS.